Japan Ai-Based Clinical Trials Solution Provider Market
Global Market
Related Markets
Japan ai-based clinical trials solution provider market highlights
- The Japan ai-based clinical trials solution provider market generated a revenue of USD 8.6 million in 2021 and is expected to reach USD 52.4 million by 2030.
- The Japan market is expected to grow at a CAGR of 22.2% from 2022 to 2030.
- In terms of segment, oncology was the largest revenue generating therapeutic applications in 2021.
- CVD is the most lucrative therapeutic applications segment registering the fastest growth during the forecast period.
Ai-based clinical trials solution provider market data book summary
| Market revenue in 2021 | USD 8.6 million |
| Market revenue in 2030 | USD 52.4 million |
| Growth rate | 22.2% (CAGR from 2021 to 2030) |
| Largest segment | Oncology |
| Fastest growing segment | CVD |
| Historical data | 2018 - 2020 |
| Base year | 2021 |
| Forecast period | 2022 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Oncology, CVD, Neurological Diseases or conditions, Metabolic diseases, Infectious diseases |
| Key market players worldwide | The Carlyle Group Inc, Mendel.ai, Median Technologies, SAI.TECH Global Corp, Alphabet Inc Class A, Exscientia PLC ADR |
Other key industry trends
- In terms of revenue, Japan accounted for 0.7% of the global ai-based clinical trials solution provider market in 2021.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China ai-based clinical trials solution provider market is projected to lead the regional market in terms of revenue in 2030.
- Australia is the fastest growing regional market in Asia Pacific and is projected to reach USD 123.2 million by 2030.
In Japan, there is a large percentage of population above 65 years of age. Hence, the government focuses on areas such as repairing damaged organ, replacing damaged organs with stem cells, and developing better cost-effective medicines.
These factors are also responsible for development of advanced solutions for clinical trials in the country. In addition, Japan is an attractive market for outsourcing for developed nations. The regulatory process is also supportive of faster clinical trial approval.
For instance, clinical trials can be started once the probable benefits are demonstrated by carrying out relatively smaller number of clinical trials. This creates opportunities for companies to enter into the market, thereby supporting local as well as international players providing technology-based solutions for clinical research.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Artificial Intelligence Based Clinical Trials Solution Provider Market
Artificial Intelligence Based Clinical Trials Solution Provider Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Alphabet Inc Class A | View profile | 180,895 | 1600 Amphitheatre Parkway, Mountain View, CA, United States, 94043 | www.abc.xyz |
| Mendel.ai | View profile | 101-250 | San Jose, California, United States, North America | mendel.ai/ |
| The Carlyle Group Inc | View profile | 2,200 | 1001 Pennsylvania Avenue, NW, Washington, DC, United States, 20004-2505 | www.carlyle.com |
| Exscientia PLC ADR | View profile | 483 | Oxford Science Park, The Schrodinger Building, Oxford, United Kingdom, OX4 4GE | www.exscientia.ai |
| SAI.TECH Global Corp | View profile | 37 | 195 Pearl’s Hill Terrace, Number 01-05, Singapore, Singapore, 168976 | www.sai.tech |
| Median Technologies | View profile | 101-250 | Valbonne, Provence-Alpes-Cote d'Azur, France, Europe | www.mediantechnologies.com |
Japan artificial intelligence based clinical trials solution provider market
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to AI-based Clinical Trials Solution Provider Market will help companies and investors design strategic landscapes.
Oncology was the largest segment with a revenue share of 23.26% in 2021.
Horizon Databook has segmented the Japan ai-based clinical trials solution provider market based on oncology, cvd, neurological diseases or conditions, metabolic diseases, infectious diseases covering the revenue growth of each sub-segment from 2018 to 2030.
In Japan, there is a large percentage of population above 65 years of age. Hence, the government focuses on areas such as repairing damaged organ, replacing damaged organs with stem cells, and developing better cost-effective medicines.
These factors are also responsible for development of advanced solutions for clinical trials in the country. In addition, Japan is an attractive market for outsourcing for developed nations. The regulatory process is also supportive of faster clinical trial approval.
For instance, clinical trials can be started once the probable benefits are demonstrated by carrying out relatively smaller number of clinical trials. This creates opportunities for companies to enter into the market, thereby supporting local as well as international players providing technology-based solutions for clinical research.
- Japan Ai-Based Clinical Trials Solution Provider Market Therapeutic Applications Outlook (Revenue, USD Million , 2018-2030)
- Oncology
- CVD
- Neurological Diseases or conditions
- Metabolic diseases
- Infectious diseases
- Others
- Japan Ai-Based Clinical Trials Solution Provider Market Clinical Trial Phase Outlook (Revenue, USD Million , 2018-2030)
- Phase-I
- Phase-II
- Phase-III
- Japan Ai-Based Clinical Trials Solution Provider Market End User Outlook (Revenue, USD Million , 2018-2030)
- Pharmaceutical Companies
- Academia
- Others
Reasons to subscribe to artificial intelligence based clinical trials solution provider market databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of artificial intelligence based clinical trials solution provider market databook
- Our clientele includes a mix of artificial intelligence based clinical trials solution provider market companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan artificial intelligence based clinical trials solution provider market, including forecasts for subscribers. This country databook contains high-level insights into Japan artificial intelligence based clinical trials solution provider market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Japan Ai-Based Clinical Trials Solution Provider Market, 2018-2030 (US$M)
Japan artificial intelligence based clinical trials solution provider market statistics, by therapeutic applications, 2018-2030 (US$M)
